Dalia H El-Kashef
Overview
Explore the profile of Dalia H El-Kashef including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohamed N, Suddek G, El-Kashef D
Int Immunopharmacol
. 2025 Feb;
148:114169.
PMID: 39904683
No abstract available.
2.
Mohamed N, Suddek G, El-Kashef D
Int Immunopharmacol
. 2025 Feb;
148:114171.
PMID: 39894706
No abstract available.
3.
Bahriz H, Abdelaziz R, El-Kashef D
Toxicol Appl Pharmacol
. 2024 Dec;
495:117202.
PMID: 39672344
Chemotherapeutic medication-induced systemic toxicity makes cancer treatment less effective. Thus, the need for drug repurposing, which aids in the development of safe and efficient cancer therapies, is urgent. The primary...
4.
Bahriz H, Abdelaziz R, El-Kashef D
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Dec;
PMID: 39636403
The present research was performed to examine the possible capability of allopurinol to prevent developing hepatocellular carcinoma (HCC) and to explore the fundamental mechanisms that control the hepatoprotective effect considering...
5.
El-Kashef D, Sewilam H
Tissue Cell
. 2024 Sep;
91:102569.
PMID: 39303437
Materials And Methods: Mice received Nico (50 and 100 mg/kg. orally) for 7 days and LCA (125 mg/kg, i.p.) was injected for the last 4 days two times daily. Results:...
6.
Apocynin alleviates thioacetamide-induced acute liver injury: Role of NOX1/NOX4/NF-κB/NLRP3 pathways
El-Kashef D, Abdel-Rahman N, Sharawy M
Cytokine
. 2024 Sep;
183:156747.
PMID: 39236429
The liver has a distinctive capacity to regenerate, yet severe acute injury can be life-threatening if not treated appropriately. Inflammation and oxidative stress are central processes implicated in the pathophysiology...
7.
Abouelezz H, El-Kashef D, Abdelaziz R, Nader M
Food Chem Toxicol
. 2024 Aug;
193:114968.
PMID: 39214269
Existing work intended to investigate the outcomes of the localized mitochondrial antioxidant tiron (TR) alone or in combination with doxorubicin (DOX) in 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis in rats and the...
8.
Abdelrahaman D, Habotta O, Taher E, El-Ashry E, Ibrahim I, Abdeen A, et al.
Front Pharmacol
. 2024 Aug;
15:1379908.
PMID: 39211776
The major contribution of myocardial damage to global mortalities raises debate regarding the exploration of new therapeutic strategies for its treatment. Therefore, our study investigated the counteracting effect of tiron...
9.
Eisa N, Helmy S, El-Kashef D, El-Sherbiny M, Elsherbiny N
Int Immunopharmacol
. 2024 Jan;
128:111514.
PMID: 38199193
Background: Diabetic neuropathy (DN) is a serious microvascular complication and a major cause of morbidity and mortality in diabetes mellitus. It is characterized by neurodegeneration of terminal sensory nerve fibers...
10.
El-Kashef D, Rahim M
BMC Pharmacol Toxicol
. 2023 Dec;
24(1):76.
PMID: 38082292
Cyclophosphamide (CP) is an antineoplastic drug commonly used worldwide. Despite its spread, it causes fatal organ toxicity. Lung toxicity is a serious side effect of CP. Actually, in the past...